Biotechnology IGB develops and optimizes processes, products and technologies in the fields of health, chemistry and process industry, as well as environment and energy. We combine the highest scientific standards with professional know-how in our competence areas – always with a view to economic efficiency and sustainability. Our strengths are offering complete solutions from the laboratory to the pilot scale. Customers also benefit from the cooperation between our five R&D departments in Stuttgart and the institute branches located in Leuna und Straubing. The constructive interplay of the various disciplines at our institute opens up new approaches in areas such as medical engineering, nanotechnology, industrial biotechnology, and environmental technology. Fraunhofer IGB is one of 69 institutes and independent research units of the Fraunhofer-Gesellschaft, Europe´s leading organization for applied research.
CompetencesInterfacial Engineering and Materials Science Molecular Biotechnology Physical Process Technology Environmental Biotechnology and Bioprocess Engineering Cell and Tissue Engineering Fraunhofer Center for Chemical-Biotechnological Processes CBP, Leuna branch Bio, Electro, and Chemocatalysis BioCat, Straubing branch
HEALTHCoatings and biomaterials for medical applications Molecular diagnostics Personalized medicine Drug discovery and development Formulation and release systems Food and cosmetics
CHEMISTRY AND PROCESS INDUSTRYFunctional surfaces and materials Fermentation and biocatalysis Biobased chemicals Biorefinery concepts Electrochemical conversion Downstream processing
ENVIRONMENT AND ENERGYWater and wastewater technologies Water monitoring (Re)processing of raw and residual materials Energy conversion and storage Bioenergy
Roll-to-roll processes: Network R2RNet bundles expertise for the continuous functionalization of surfaces
Roll-to-roll (R2R) processes, in which, for example, films, textiles, flat membranes, metal foils or even ultra-thin glass are functionalized, play an important role in…
Impact statement: New technology that recreates some of the complexity of the human retina may help scientists study eye disease and screen for drug side effects that…